When analyzing the co-expression pattern for these two markers inside the CD45-negative subset, we watched CK (+) EpCAM (-) population underwent the largest increase with disease progression from CIN to cancer (with the peak at stage IA), with CK (+) EpCAM (+) cell counts being also elevated. Here, PTPRC is linked to cancer.